We are live on !
Find out more
Whitebox Advisors Portfolio holdings
AUM
$7.65B
Turnover
32.48%
1-Year Est. Return
13.87%
Whitebox Advisors is a multi-strategy hedge fund manager founded in 1999. It invests across asset classes and markets for institutions, private entities and qualified individuals. Its trades include convertible arbitrage, distressed credit and municipal bonds. Robert Vogel, a partner and the firm's chief investment officer, is its majority owner.
This Fund
S&P 500
This Quarter Est. Return
+1.93%
1 Year Est. Return
+13.87%
3 Year Est. Return
+24.22%
5 Year Est. Return
+33.25%
10 Year Est. Return
+180.55%
AUM
$7.65B
AUM Growth
-$592M
(-7.2%)
Cap. Flow
-$3.5B
Cap. Flow % of AUM
Cap. Flow %
-45.77%
Top 10 Holdings %
Top 10 Hldgs %
31.69%
Holding
745
New
163
Increased
24
Reduced
37
Closed
79
Avg Time Held
Equity + Options
0.8
years
Top 10 Avg Time Held
Equity + Options
0.5
years
Top 20 Avg Time Held
Equity + Options
0.9
years
Avg Time Held Equity only
0.8
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Techne
TECH
|
+$113M |
| 2 |
Caesars Entertainment
CZR
|
+$92.1M |
| 3 |
Super Micro Computer Depositary Shares 7% Series A Preferred Stock
SMCIP
|
+$75.2M |
| 4 |
Azul S.A.
AZUL
|
+$73.8M |
| 5 |
Apogee Therapeutics
APGE
|
+$40.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chart Industries
GTLS
|
+$137M |
| 2 |
Terns Pharmaceuticals
TERN
|
+$52.7M |
| 3 |
Liberty Broadband Class C
LBRDK
|
+$49.6M |
| 4 |
Masimo
MASI
|
+$48M |
| 5 |
Carnival PLC
CUK
|
+$33.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.51% |
| 2 | Financials | 9.04% |
| 3 | Healthcare | 5.77% |
| 4 | Industrials | 2.04% |
| 5 | Energy | 1.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
176
Abony Acquisition Corp I
AACO
$315M
| $2.97M | 0.04% |
+300,000
| New | +$2.97M |
2026 Q2
0 quarters
|
|
|
APUR
177
Aperture AC
APUR
$148M
| $2.97M | 0.04% |
+300,000
| New | +$2.97M |
2026 Q2
0 quarters
|
|
178
Mountain Crest Acquisition 6 Corp
MCAH
$87.4M
| $2.83M | 0.04% |
+285,000
| New | +$2.83M |
2026 Q2
0 quarters
|
|
179
Newbridge Acquisition Ltd
NBRG
$76.6M
| $2.79M | 0.04% |
280,000
| – | – |
2026 Q1
1 quarter
|
|
180
Chenghe Acquisition III Co
CHEC
$178M
| $2.79M | 0.04% |
275,000
| – | – |
2025 Q4
2 quarters
|
|
181
PIMCO New York Municipal Income Fund II
PNI
$159M
| $2.75M | 0.04% |
387,958
| – | – |
2026 Q1
1 quarter
|
|
182
Black Spade Acquisition III Co
BIII
$234M
| $2.75M | 0.04% |
276,200
| – | – |
2026 Q1
1 quarter
|
|
183
BlackRock MuniYield New York Quality Fund
MYN
$885M
| $2.74M | 0.04% |
270,047
-3,640
| -1% | -$36.2K |
2026 Q1
1 quarter
|
|
|
NHIC
184
DELISTED
NewHold Investment Corp III
NHIC
| $2.72M | 0.04% |
249,574
-426
| -0.2% | -$4.58K |
2025 Q2
4 quarters
|
|
185
Launch One Acquisition Corp
LPAA
$82.9M
| $2.71M | 0.04% |
250,000
| – | – |
2024 Q4
6 quarters
|
|
186
DELISTED
Archimedes Tech SPAC Partners II Co
ATII
| $2.7M | 0.04% |
250,000
| – | – |
2025 Q2
4 quarters
|
|
187
Oaktree Acquisition Corp III Life Sciences
OACC
$263M
| $2.68M | 0.04% |
250,000
| – | – |
2025 Q2
4 quarters
|
|
188
1RT Acquisition Corp
ONCH
$224M
| $2.66M | 0.03% |
260,000
| – | – |
2025 Q3
3 quarters
|
|
189
FACT II Acquisition Corp
FACT
$263M
| $2.66M | 0.03% |
250,000
| – | – |
2025 Q2
4 quarters
|
|
190
Sabre
SABR
$727M
| $2.65M | 0.03% |
1,266,379
-5,837
| -0.5% | -$10.2K |
2026 Q1
1 quarter
|
|
191
United Acquisition Corp I
UAC
$138M
| $2.58M | 0.03% |
260,000
| – | – |
2026 Q1
1 quarter
|
|
192
Blue Water Acquisition Corp III
BLUW
$336M
| $2.58M | 0.03% |
250,000
| – | – |
2025 Q3
3 quarters
|
|
193
Oyster Enterprises II Acquisition Corp
OYSE
$354M
| $2.57M | 0.03% |
250,000
| – | – |
2025 Q3
3 quarters
|
|
194
Silver Pegasus Acquisition Corp
SPEG
$160M
| $2.57M | 0.03% |
250,000
| – | – |
2025 Q3
3 quarters
|
|
|
VACI
195
DELISTED
Viking Acquisition Corp I
VACI
| $2.56M | 0.03% |
250,000
| – | – |
2025 Q4
2 quarters
|
|
196
Pimco California Municipal Income Fund
PCQ
$159M
| $2.55M | 0.03% |
284,471
| – | – |
2025 Q3
3 quarters
|
|
197
Westin Acquisition Corp
WSTN
$80.9M
| $2.52M | 0.03% |
250,000
| – | – |
2025 Q4
2 quarters
|
|
198
LaFayette Acquisition Corp
LAFA
$161M
| $2.52M | 0.03% |
250,000
| – | – |
2025 Q4
2 quarters
|
|
199
Safeguard Acquisition Corp
SAC
$317M
| $2.52M | 0.03% |
250,000
| – | – |
2026 Q1
1 quarter
|
|
|
FXACU
200
FortuneX Acquisition Corp Units
FXACU
$78.8M
| $2.51M | 0.03% |
+250,000
| New | +$2.51M |
2026 Q2
0 quarters
|
|
Similar funds
Whitebox Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Whitebox Advisors held 745 positions worth $7.65B, down 7.2% from $8.24B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Whitebox Advisors withdrew a net $3.5B in Q2 2026, closing 79 positions and reducing 37 holdings. Its most notable exit was Terns Pharmaceuticals, an estimated $52.7M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 77% of assets, down from 81% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Whitebox Advisors opened a new position in Bio-Techne worth $148M.
- Whitebox Advisors's largest Q2 2026 buy was Bio-Techne: 2,100,001 shares worth $148M.
- Whitebox Advisors added most to Caesars Entertainment in Q2 2026, an estimated $92.1M increase.
- Whitebox Advisors's biggest Q2 2026 reduction was Chart Industries, cutting an estimated $137M.
- Whitebox Advisors fully exited Terns Pharmaceuticals in Q2 2026, selling an estimated $52.7M.
- Whitebox Advisors's ten largest holdings make up 32% of its $7.65B portfolio in Q2 2026.
- Whitebox Advisors opened 163 new positions and closed 79 in Q2 2026.
- Whitebox Advisors's portfolio value fell 7.2% quarter-over-quarter to $7.65B.
Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.